DE19720761A1 - Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung - Google Patents

Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung

Info

Publication number: DE19720761A1
Authority: DE; Germany
Prior art keywords: secretion; proteins; attenuated; salmonella; fragments
Prior art date: 1997-05-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

DE19720761A

Other languages

German (de)

English (en)

Inventor

Peter Dr Donner

Werner Prof Goebel

Andreas Dr Demuth

Ivaylo Dr Gentschev

Juergen Dr Hess

Stefan Prof Kaufmann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee

Schering AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-07

Filing date

1997-05-07

Publication date

1998-11-12

1997-05-07 Application filed by Schering AG filed Critical Schering AG

1997-05-07 Priority to DE19720761A priority Critical patent/DE19720761A1/de

1998-05-07 Priority to SK1517-99A priority patent/SK151799A3/sk

1998-05-07 Priority to PCT/EP1998/002679 priority patent/WO1998050067A2/de

1998-05-07 Priority to BR9809244-8A priority patent/BR9809244A/pt

1998-05-07 Priority to KR1019997010208A priority patent/KR20010012257A/ko

1998-05-07 Priority to EP98929286A priority patent/EP1015023A1/de

1998-05-07 Priority to HU0002752A priority patent/HUP0002752A2/hu

1998-05-07 Priority to CA002288602A priority patent/CA2288602A1/en

1998-05-07 Priority to AU79107/98A priority patent/AU7910798A/en

1998-05-07 Priority to PL98336786A priority patent/PL336786A1/xx

1998-05-07 Priority to JP54774098A priority patent/JP2002501507A/ja

1998-05-07 Priority to IL13252198A priority patent/IL132521A0/xx

1998-05-07 Priority to CN98804817A priority patent/CN1255067A/zh

1998-05-07 Priority to TR1999/02671T priority patent/TR199902671T2/xx

1998-05-07 Priority to EEP199900516A priority patent/EE9900516A/xx

1998-11-12 Publication of DE19720761A1 publication Critical patent/DE19720761A1/de

1999-09-28 Priority to IS5199A priority patent/IS5199A/is

1999-11-02 Priority to BG103850A priority patent/BG103850A/xx

1999-11-05 Priority to NO995429A priority patent/NO995429L/no

Status Withdrawn legal-status Critical Current

Links

230000002238 attenuated effect Effects 0.000 title claims abstract description 12
238000002255 vaccination Methods 0.000 title claims abstract description 8
108090000623 proteins and genes Proteins 0.000 title claims description 67
102000004169 proteins and genes Human genes 0.000 title claims description 38
239000012634 fragment Substances 0.000 title claims description 36
230000028327 secretion Effects 0.000 title claims description 34
241000607142 Salmonella Species 0.000 title claims description 17
229940031567 attenuated vaccine Drugs 0.000 title claims description 6
238000000034 method Methods 0.000 title abstract description 4
230000015572 biosynthetic process Effects 0.000 title description 3
238000003786 synthesis reaction Methods 0.000 title description 3
230000008569 process Effects 0.000 title description 2
239000000427 antigen Substances 0.000 claims description 22
102000036639 antigens Human genes 0.000 claims description 22
108091007433 antigens Proteins 0.000 claims description 22
108010006464 Hemolysin Proteins Proteins 0.000 claims description 16
239000003228 hemolysin Substances 0.000 claims description 16
230000035558 fertility Effects 0.000 claims description 14
210000004340 zona pellucida Anatomy 0.000 claims description 11
239000013606 secretion vector Substances 0.000 claims description 7
101150024289 hly gene Proteins 0.000 claims description 5
101150021605 hlyA gene Proteins 0.000 claims description 4
230000028993 immune response Effects 0.000 abstract description 5
235000018102 proteins Nutrition 0.000 description 33
102000037865 fusion proteins Human genes 0.000 description 21
108020001507 fusion proteins Proteins 0.000 description 21
230000032258 transport Effects 0.000 description 13
239000006228 supernatant Substances 0.000 description 12
239000002299 complementary DNA Substances 0.000 description 11
239000012528 membrane Substances 0.000 description 11
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 11
239000013598 vector Substances 0.000 description 9
101000976428 Homo sapiens Zona pellucida sperm-binding protein 4 Proteins 0.000 description 8
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 7
150000001413 amino acids Chemical class 0.000 description 7
230000004927 fusion Effects 0.000 description 7
239000000020 Nitrocellulose Substances 0.000 description 6
239000012722 SDS sample buffer Substances 0.000 description 6
238000005119 centrifugation Methods 0.000 description 6
239000000499 gel Substances 0.000 description 6
229920001220 nitrocellulos Polymers 0.000 description 6
229920002401 polyacrylamide Polymers 0.000 description 6
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
230000009466 transformation Effects 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 5
241000620209 Escherichia coli DH5[alpha] Species 0.000 description 5
238000012408 PCR amplification Methods 0.000 description 5
239000013612 plasmid Substances 0.000 description 5
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 5
239000000047 product Substances 0.000 description 5
238000001262 western blot Methods 0.000 description 5
101000818870 Homo sapiens Zona pellucida sperm-binding protein 2 Proteins 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
230000029087 digestion Effects 0.000 description 4
230000002209 hydrophobic effect Effects 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
230000007017 scission Effects 0.000 description 4
210000001744 T-lymphocyte Anatomy 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
230000036039 immunity Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
229960005486 vaccine Drugs 0.000 description 3
241000894006 Bacteria Species 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
239000000872 buffer Substances 0.000 description 2
238000010367 cloning Methods 0.000 description 2
238000004925 denaturation Methods 0.000 description 2
230000036425 denaturation Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
101150079947 hlyB gene Proteins 0.000 description 2
101150104052 hlyD gene Proteins 0.000 description 2
230000003053 immunization Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
230000002611 ovarian Effects 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
210000000680 phagosome Anatomy 0.000 description 2
210000001550 testis Anatomy 0.000 description 2
230000005945 translocation Effects 0.000 description 2
108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
101710134191 24 kDa antigen Proteins 0.000 description 1
101100378273 Brachyspira hyodysenteriae acpP gene Proteins 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
108020004414 DNA Proteins 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000976442 Homo sapiens Zona pellucida sperm-binding protein 3 Proteins 0.000 description 1
241000186779 Listeria monocytogenes Species 0.000 description 1
108700027766 Listeria monocytogenes hlyA Proteins 0.000 description 1
101100098690 Listeria monocytogenes serovar 1/2a (strain ATCC BAA-679 / EGD-e) hly gene Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
102100023058 NHP2-like protein 1 Human genes 0.000 description 1
101710177157 NHP2-like protein 1 Proteins 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
102000018819 Protein Translocation Systems Human genes 0.000 description 1
108010052646 Protein Translocation Systems Proteins 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
229940124842 Salmonella vaccine Drugs 0.000 description 1
230000005867 T cell response Effects 0.000 description 1
241000607626 Vibrio cholerae Species 0.000 description 1
108010074006 Zona Pellucida Glycoproteins Proteins 0.000 description 1
102000008937 Zona Pellucida Glycoproteins Human genes 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
101150015540 apxIIC gene Proteins 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003433 contraceptive agent Substances 0.000 description 1
230000002254 contraceptive effect Effects 0.000 description 1
101150096136 cyaC gene Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
210000000172 cytosol Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000002744 extracellular matrix Anatomy 0.000 description 1
239000000284 extract Substances 0.000 description 1
231100000502 fertility decrease Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
101150039987 hlyC gene Proteins 0.000 description 1
102000055963 human ZP2 Human genes 0.000 description 1
102000057586 human ZP4 Human genes 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
208000021267 infertility disease Diseases 0.000 description 1
231100000503 infertility induction Toxicity 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000000203 mixture Substances 0.000 description 1
230000016379 mucosal immune response Effects 0.000 description 1
210000000287 oocyte Anatomy 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
238000003259 recombinant expression Methods 0.000 description 1
210000005000 reproductive tract Anatomy 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
230000009962 secretion pathway Effects 0.000 description 1
210000000582 semen Anatomy 0.000 description 1
241000894007 species Species 0.000 description 1
238000010186 staining Methods 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
230000002381 testicular Effects 0.000 description 1
229940125575 vaccine candidate Drugs 0.000 description 1
229940118696 vibrio cholerae Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Reproductive Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Virology (AREA)
Gynecology & Obstetrics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Farming Of Fish And Shellfish (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DE19720761A 1997-05-07 1997-05-07 Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung Withdrawn DE19720761A1 (de)

Priority Applications (18)

Application Number	Priority Date	Filing Date	Title
DE19720761A DE19720761A1 (de)	1997-05-07	1997-05-07	Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung
PL98336786A PL336786A1 (en)	1997-05-07	1998-05-07	Application of a secretion vector in controlling fertility by means of an orally administered vaccine
JP54774098A JP2002501507A (ja)	1997-05-07	1998-05-07	出生調節用経口ワクチン接種における分泌ベクターの使用
BR9809244-8A BR9809244A (pt)	1997-05-07	1998-05-07	Aplicação de um vetor de secreção para o controle da fertilidade mediante vacinação oral
KR1019997010208A KR20010012257A (ko)	1997-05-07	1998-05-07	분비 벡터의 경구 백신접종에 의한 수정 조절 용도
EP98929286A EP1015023A1 (de)	1997-05-07	1998-05-07	Verwendung eines sekretionsvektors zur fertilitätskontrolle durch orale vakzinierung
HU0002752A HUP0002752A2 (hu)	1997-05-07	1998-05-07	Egy szekréciós vektor alkalmazása termékenység-szabályozásra orális vakcinálással
CA002288602A CA2288602A1 (en)	1997-05-07	1998-05-07	Use of a secretion vector for fertility control by oral vaccination
AU79107/98A AU7910798A (en)	1997-05-07	1998-05-07	Use or a secretion vector for fertility control by oral vaccination
SK1517-99A SK151799A3 (en)	1997-05-07	1998-05-07	Use or a secretion vector for fertility control by oral vaccination
PCT/EP1998/002679 WO1998050067A2 (de)	1997-05-07	1998-05-07	Verwendung eines sekretionsvektors zur fertilitätskontrolle durch orale vakzinierung
IL13252198A IL132521A0 (en)	1997-05-07	1998-05-07	Use of a secretion vector for birth control by oral vaccination
CN98804817A CN1255067A (zh)	1997-05-07	1998-05-07	一种通过口服接种用于节育的分泌型载体的应用
TR1999/02671T TR199902671T2 (xx)	1997-05-07	1998-05-07	Bir salg�lama vekt�r�n�n do�um kontrol�nde oral vaksinasyon vas�tas�yla kullan�l��.
EEP199900516A EE9900516A (et)	1997-05-07	1998-05-07	Sekretsioonivektori kasutamine viljastuskontrolliks peroraalse vaktsineerimise abil
IS5199A IS5199A (is)	1997-05-07	1999-09-28	Notkun á seytisgenaferju fyrir frjósemisstýringu með ónæmingu um munn
BG103850A BG103850A (en)	1997-05-07	1999-11-02	The application of secreting vector for fertility control by peroral vaccination
NO995429A NO995429L (no)	1997-05-07	1999-11-05	Anvendelse av en sekresjonsvektor for fertilitetskontroll ved oral vaksinasjon

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19720761A DE19720761A1 (de)	1997-05-07	1997-05-07	Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung

Publications (1)

Publication Number	Publication Date
DE19720761A1 true DE19720761A1 (de)	1998-11-12

Family

ID=7829783

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE19720761A Withdrawn DE19720761A1 (de)	1997-05-07	1997-05-07	Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung

Country Status (18)

Country	Link
EP (1)	EP1015023A1 (hu)
JP (1)	JP2002501507A (hu)
KR (1)	KR20010012257A (hu)
CN (1)	CN1255067A (hu)
AU (1)	AU7910798A (hu)
BG (1)	BG103850A (hu)
BR (1)	BR9809244A (hu)
CA (1)	CA2288602A1 (hu)
DE (1)	DE19720761A1 (hu)
EE (1)	EE9900516A (hu)
HU (1)	HUP0002752A2 (hu)
IL (1)	IL132521A0 (hu)
IS (1)	IS5199A (hu)
NO (1)	NO995429L (hu)
PL (1)	PL336786A1 (hu)
SK (1)	SK151799A3 (hu)
TR (1)	TR199902671T2 (hu)
WO (1)	WO1998050067A2 (hu)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6989160B2 (en) *	2002-03-19	2006-01-24	Council Of Scientific And Industrial Research	Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10206325A1 (de) *	2002-02-14	2003-09-04	Medinnova Ges Med Innovationen	Ummantelter Mikroorganismus
EP1882743A4 (en) *	2005-05-12	2012-08-01	Ajinomoto Kk	PROTEIN PRODUCTION PROCESS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE177787T1 (de) *	1990-11-21	1999-04-15	Univ Washington	Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
US5480799A (en) *	1993-12-10	1996-01-02	The University Of North Carolina At Chapel Hill	Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope

1997
- 1997-05-07 DE DE19720761A patent/DE19720761A1/de not_active Withdrawn
1998
- 1998-05-07 AU AU79107/98A patent/AU7910798A/en not_active Abandoned
- 1998-05-07 IL IL13252198A patent/IL132521A0/xx unknown
- 1998-05-07 JP JP54774098A patent/JP2002501507A/ja active Pending
- 1998-05-07 SK SK1517-99A patent/SK151799A3/sk unknown
- 1998-05-07 CA CA002288602A patent/CA2288602A1/en not_active Abandoned
- 1998-05-07 KR KR1019997010208A patent/KR20010012257A/ko not_active Application Discontinuation
- 1998-05-07 WO PCT/EP1998/002679 patent/WO1998050067A2/de not_active Application Discontinuation
- 1998-05-07 PL PL98336786A patent/PL336786A1/xx unknown
- 1998-05-07 HU HU0002752A patent/HUP0002752A2/hu unknown
- 1998-05-07 TR TR1999/02671T patent/TR199902671T2/xx unknown
- 1998-05-07 CN CN98804817A patent/CN1255067A/zh active Pending
- 1998-05-07 BR BR9809244-8A patent/BR9809244A/pt not_active IP Right Cessation
- 1998-05-07 EE EEP199900516A patent/EE9900516A/xx unknown
- 1998-05-07 EP EP98929286A patent/EP1015023A1/de not_active Withdrawn
1999
- 1999-09-28 IS IS5199A patent/IS5199A/is unknown
- 1999-11-02 BG BG103850A patent/BG103850A/xx unknown
- 1999-11-05 NO NO995429A patent/NO995429L/no not_active Application Discontinuation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6989160B2 (en) *	2002-03-19	2006-01-24	Council Of Scientific And Industrial Research	Therapeutic/edible compositions comprising herbal ingredients and methods for treating hyperglycemia

Also Published As

Publication number	Publication date
IS5199A (is)	1999-09-28
SK151799A3 (en)	2000-06-12
NO995429L (no)	2000-01-07
WO1998050067A9 (de)	1999-03-25
TR199902671T2 (xx)	2000-09-21
BG103850A (en)	2000-05-31
EE9900516A (et)	2000-06-15
IL132521A0 (en)	2001-03-19
BR9809244A (pt)	2000-06-27
WO1998050067A2 (de)	1998-11-12
AU7910798A (en)	1998-11-27
CA2288602A1 (en)	1998-11-12
NO995429D0 (no)	1999-11-05
HUP0002752A2 (hu)	2000-12-28
PL336786A1 (en)	2000-07-17
EP1015023A1 (de)	2000-07-05
KR20010012257A (ko)	2001-02-15
JP2002501507A (ja)	2002-01-15
WO1998050067A3 (de)	2000-06-29
CN1255067A (zh)	2000-05-31

Publication	Publication Date	Title
DE69331733T2 (de)	2002-08-22	Rekombinantes vielwertiges m-protein-vakzin
DE69131014T2 (de)	1999-10-07	Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
DE68925138T2 (de)	1996-06-13	Verfahren zur Herstellung von Proteinen durch Verwendung von CKS-Fusionsproteinen
DE68929369T2 (de)	2002-09-26	DNS Fragmente, die für Borrelia burgdorferi OspA kodieren, Verfahren zur Herstellung von OspA Polypeptiden, und diagnostische Verfahren basierend auf diesen DNS Fragmenten
DE3781765T2 (de)	1993-04-22	Verfahren zur herstellung eines polypeptides.
DE68924162T2 (de)	1996-04-25	Stressproteine und verwendungen dafür.
DE69331269T2 (de)	2002-08-08	Verfahren zur herstellung von antikörpern
JPH06206900A (ja)	1994-07-26	融合タンパク質
Magaña-Ortíz et al.	2018	Extracellular expression in Aspergillus niger of an antibody fused to Leishmania sp. antigens
DE69333560T2 (de)	2006-07-13	Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
DE19720761A1 (de)	1998-11-12	Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung
DE4005874A1 (de)	1991-11-07	Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine
EP1048732A1 (de)	2000-11-02	Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen
DE3879823T2 (de)	1993-07-08	Verfahren zur herstellung von menschlichem wachstumshormon.
DE69535705T2 (de)	2009-04-16	Funktionelles aufspüren und/oder expressionsvektoren bei mycobakterien
DE60021719T2 (de)	2006-06-08	Mikrobielle proteinexpressionssysteme
DE69112834T2 (de)	1996-04-04	Einführung der transkription regulierende nukleotidsequenz.
JPH03501801A (ja)	1991-04-25	クローン化プロテインｇ変異体遺伝子及びそれから発現されたプロテインｇ変異体
WO1993010246A1 (en)	1993-05-27	Membrane expression of heterologous genes
IT1244706B (it)	1994-08-08	Plasmide pctd isolato da chlamydia trachomatis serotipo d, suoi geni e proteine da essi codificate; plasmidi ricombinanti per l'espressionedi detti geni in sistemi eterologhi come proteine ricombinanti di fusione, preparazione di dette proteine ricombinanti e loro uso nella formulazione di vaccini e/o diagnostici
EP0627006B1 (de)	1997-05-02	Hybrid-dna, die eine untereinheit eines bakteriellen toxins mit einer haemolysin kodiert
DE3587473T2 (de)	1993-11-04	Klonierungstraeger zum klonieren eines grossen dns-fragmentes und impfstoff enthaltend 987p fimrialprotein.
DE19903345A1 (de)	2000-08-03	Kompartimentierung von rekombinanten Polypeptiden in Wirtszellen
AU1471202A (en)	2002-03-14	Use of a secretion vector for fertility control by oral vaccination
DE69009883T2 (de)	1994-09-22	Thermo-induzierbare Expression von heterologen Genen in Bacillus subtilis und Mittel und Verfahren zu deren Ausführung.

Legal Events

Date	Code	Title	Description
1998-11-12	OP8	Request for examination as to paragraph 44 patent law
2002-09-12	8130	Withdrawal

DE19720761A1 - Verfahren zur Synthese und Sekretion von zur Kontrazeption geeigneter Proteine oder Proteinfragmente durch attenuierte Salmonellen oder einen anderen Gram-negativen attenuierten Impfstamm zur Erzeugung einer oralen Vakzinierung - Google Patents

Info

Links

Classifications

Landscapes

Priority Applications (18)

Applications Claiming Priority (1)

Publications (1)

Family

ID=7829783

Family Applications (1)

Country Status (18)

Cited By (1)

Families Citing this family (2)

Family Cites Families (2)

Cited By (1)

Also Published As

Similar Documents

Legal Events